Bookmark and Share

Compound Summary for: CID 66265

(2S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine

Also known as: Dexfenfluramine (INN), AC1L24ZO, AC1Q4JS0, NCGC00247710-01, CHEMBL248702, CHEBI:439329, PDSP1_000695, PDSP1_001419
Molecular Formula: C12H16F3N   Molecular Weight: 231.25735   InChIKey: DBGIVFWFUFKIQN-VIFPVBQESA-N
Dexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug. It was for some years in the mid-1990s approved by the United States Food and Drug Administration for the purposes of weight loss. However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _